Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CSF and serum interferon in multiple sclerosis: longitudinal study.

R Salonen

    Neurology
    |December 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical utility gene card for: Meckel syndrome.

    European journal of human genetics : EJHG·2011
    Same author

    Comparison of rizatriptan and sumatriptan.

    Headache·2008
    Same author

    Low maximal oxygen uptake is associated with elevated depressive symptoms in middle-aged men.

    European journal of epidemiology·2006
    Same author

    Increased augmentation of central blood pressure is associated with increases in carotid intima-media thickness in type 2 diabetic patients.

    Diabetologia·2005
    Same author

    C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

    Diabetologia·2004
    Same author

    Hepatic lipase C-480T polymorphism modifies the effect of HDL cholesterol on the risk of acute myocardial infarction in men: a prospective population based study.

    Journal of medical genetics·2004
    Same journal

    Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

    Neurology·2026
    Same journal

    Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

    Neurology·2026
    Same journal

    Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

    Neurology·2026
    Same journal

    Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

    Neurology·2026
    Same journal

    Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

    Neurology·2026
    Same journal

    At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

    Neurology·2026
    See all related articles

    Interferon (IFN) was not detected in the cerebrospinal fluid (CSF) or serum of multiple sclerosis patients. This study utilized a sensitive bioassay to analyze patient samples for the presence of IFN.

    Area of Science:

    • Neuroimmunology
    • Virology
    • Biochemistry

    Background:

    • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
    • Interferons (IFNs) are cytokines with roles in immune response and viral defense.
    • The presence and role of IFN in MS pathogenesis remain areas of investigation.

    Purpose of the Study:

    • To investigate the presence of interferon (IFN) in the serum and cerebrospinal fluid (CSF) of patients diagnosed with multiple sclerosis (MS).

    Main Methods:

    • A sensitive interferon (IFN) bioassay was employed.
    • The bioassay required minimal sample volumes.
    • Detection limits were established at 0.5 IU/ml for CSF and 4 IU/ml for serum.

    Main Results:

    Related Experiment Videos

    • A total of 228 paired CSF and serum samples from 31 MS patients were analyzed.
    • No detectable levels of interferon (IFN) were found in any of the tested serum samples.
    • No detectable levels of interferon (IFN) were found in any of the tested CSF samples.

    Conclusions:

    • The findings suggest that circulating interferon (IFN) is not a significant factor in the studied cohort of multiple sclerosis patients.
    • Further research may be needed to explore the role of other immune modulators or localized IFN activity within the central nervous system.